Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Original Article
I. Mahé, M. Carrier, D. Mayeur, J. Chidiac, E. Vicaut, N. Falvo, O. Sanchez, C. Grange, M. Monreal, J.J. López-Núñez, R. Otero-Candelera, G.L. Gal, E. Yeo, M. Righini, H. Robert-Ebadi, M.V. Huisman, F.A. Klok, P. Westerweel, G. Agnelli, C. Becattini, A. Bamias, K. Syrigos, S. Szmit, A. Torbicki, P. Verhamme, A. Maraveyas, A.T. Cohen, C. Ay, C. Chapelle, G. Meyer, F. Couturaud, P. Mismetti, P. Girard, L. Bertoletti, and S. Laporte
N Engl J Med 2025;392:1363-1373
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.